Content deleted Content added
PinkDucky91 (talk | contribs) Filled in 2 bare reference(s) with reFill 2 |
PinkDucky91 (talk | contribs) Rescuing 2 sources and tagging 0 as dead.) #IABot (v2.0.9.5 |
||
Line 9:
==History==
In 1994 Professor Gerd Binnig founded ''Definiens''. CNT was first available with the launch of the ''eCognition'' software in May 2000. In June 2010, [[Trimble Navigation Ltd]] (NASDAQ: TRMB) acquired Definiens business asset in [[earth sciences]] markets, including eCognition software,<ref>Trimble / Definiens Joint Press Release: "Trimble Acquires Definiens’ Earth Sciences Business to Expand its GeoSpatial Portfolio". June 11, 2010. http://www.ecognition.com/sites/default/files/Trimble%20eCognition.pdf</ref> and also licensed Definiens' patented CNT.<ref>{{cite web | url=http://www.trimble.com/Corporate/About_History.aspx | title=About Trimble: Company History 1978 | Present | access-date=2024-06-20 | archive-date=2017-04-28 | archive-url=https://web.archive.org/web/20170428055555/http://www.trimble.com/corporate/about_history.aspx | url-status=live }}</ref> In 2014, Definiens was acquired by [[MedImmune]], the global biologics research and development arm of AstraZeneca, for an initial consideration of $150 million.<ref>{{Cite web|url=https://www.astrazeneca.com/media-centre/press-releases/2014/medimmune-definiens-aquisition-tissue-phenomics-26112014.html|title=MedImmune completes acquisition of Definiens - AstraZeneca|date=November 26, 2014|website=www.astrazeneca.com|access-date=June 20, 2024|archive-date=June 20, 2024|archive-url=https://web.archive.org/web/20240620230851/https://www.astrazeneca.com/media-centre/press-releases/2014/medimmune-definiens-aquisition-tissue-phenomics-26112014.html#modal-historic-confirmation|url-status=live}}</ref>
==Software==
| |||